Literature DB >> 12057605

Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox.

M Brisson1, N J Gay, W J Edmunds, N J Andrews.   

Abstract

We present data to confirm that exposure to varicella boosts immunity to herpes-zoster. We show that exposure to varicella is greater in adults living with children and that this exposure is highly protective against zoster (Incidence ratio=0.75, 95% CI, 0.63-0.89). The data is used to parameterise a mathematical model of varicella zoster virus (VZV) transmission that captures differences in exposure to varicella in adults living with and without children. Under the 'best-fit' model, exposure to varicella is estimated to boost cell-mediated immunity for an average of 20 years (95% CI, 7-41years). Mass varicella vaccination is expected to cause a major epidemic of herpes-zoster, affecting more than 50% of those aged 10-44 years at the introduction of vaccination.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12057605     DOI: 10.1016/s0264-410x(02)00180-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  88 in total

Review 1.  Economic evaluation of varicella vaccination programmes: a review of the literature.

Authors:  Thomas Hammerschmidt; Kurt Banz; Stefan Wagenpfeil; Albrecht Neiss; Peter Wutzler
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

2.  Varicella vaccination in England and Wales: cost-utility analysis.

Authors:  M Brisson; W J Edmunds
Journal:  Arch Dis Child       Date:  2003-10       Impact factor: 3.791

3.  Varicella zoster virus transmission in the vaccine era: unmasking the role of herpes zoster.

Authors:  Karen C Bloch; James G Johnson
Journal:  J Infect Dis       Date:  2012-03-27       Impact factor: 5.226

Review 4.  Update on herpes zoster vaccination: a family practitioner's guide.

Authors:  Marla Shapiro; Brent Kvern; Peter Watson; Lyn Guenther; Janet McElhaney; Allison McGeer
Journal:  Can Fam Physician       Date:  2011-10       Impact factor: 3.275

5.  Routine immunization of adults in Canada: Review of the epidemiology of vaccine-preventable diseases and current recommendations for primary prevention.

Authors:  Michael D Parkins; Shelly A McNeil; Kevin B Laupland
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

Review 6.  Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective.

Authors:  Robert W Johnson; Marie-José Alvarez-Pasquin; Marc Bijl; Elisabetta Franco; Jacques Gaillat; João G Clara; Marc Labetoulle; Jean-Pierre Michel; Luigi Naldi; Luis S Sanmarti; Thomas Weinke
Journal:  Ther Adv Vaccines       Date:  2015-07

7.  Should varicella vaccine be included in the routine immunization programme?

Authors:  Hualiang Lin; Yu Liu; Linwei Tian
Journal:  Transl Pediatr       Date:  2014-10

8.  Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses.

Authors:  Adriana Weinberg; Ann A Lazar; Gary O Zerbe; Anthony R Hayward; Ivan S F Chan; Rupert Vessey; Jeffrey L Silber; Rob R MacGregor; Kenny Chan; Anne A Gershon; Myron J Levin
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

Review 9.  Chickenpox, chickenpox vaccination, and shingles.

Authors:  P D Welsby
Journal:  Postgrad Med J       Date:  2006-05       Impact factor: 2.401

Review 10.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.